Chris MacDonald

Chris MacDonald

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

DNA Stock: 7 Things to Know About the Short Report Hammering Ginkgo Bioworks

Today, Ginko Bioworks and DNA stock are firmly in the sights of short-sellers as various claims are made about an elaborate fraud underway.

CEI Stock Continues Its Brutal Plunge After Responding to Short-Seller Report

Here's the news today that has shares of Camber Energy and CEI stock down once again, as investors digest a short report released yesterday.

Dogecoin Price Predictions: How High Can Elon Musk’s Puppy Take DOGE?

Here's what the experts think in terms of Dogecoin price predictions, for one of the most volatile meme tokens out there right now.

Crypto Stocks: Why BTBT, SOS, MARA, CAN Stocks Are Minting Gains on Tuesday

Today, a wide range of crypto stocks are moving higher as investors appear willing to take a risk-on approach to the markets right now.

ADTX Stock: The Huge Covid-19 News Lifting Aditxt Today

Today, investors in Aditxt and ADTX stock are seeing impressive gains following an announced acquisition of a company with a Covid-19 drug.